cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Taysha Gene Therapies Inc
9 own
8 watching
Current Price
$3.17
$0.53
(19.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
53.46M
52-Week High
52-Week High
3.89000
52-Week Low
52-Week Low
0.50000
Average Volume
Average Volume
5.78M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization53.46M
icon52-Week High3.89000
icon52-Week Low0.50000
iconAverage Volume5.78M
iconDividend Yield--
iconP/E Ratio--
What does the Taysha Gene Therapies Inc do?
Taysha Gene Therapies, Inc.is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. We were founded in partnership with The University of Texas Southwestern Medical Center, or UT Southwestern, to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we are advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs at no cost. Taysha Gene Therapies, Inc.principal executive offices are located at 2280 Inwood Road, Dallas, Texas 75235 and our telephone number is (214) 612-0000. Our website address is www.tayshagtx.com
Read More
How much money does Taysha Gene Therapies Inc make?
News & Events about Taysha Gene Therapies Inc.
Ticker Report
8 months ago
Taysha Gene Therapies, Inc. (NASDAQ:TSHA Get Rating) major shareholder R.A. Session II sold 295,653 shares of the companys stock in a transaction dated Tuesday, June 20th. The stock was sold at an average price of $0.71, for a total value of $209,913.63. Following the transaction, the...
Zolmax
11 months ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating)s stock had its buy rating reaffirmed by investment analysts at Needham & Company LLC in a report released on Wednesday, Benzinga reports. They currently have a $6.00 price target on the stock. Several other equities research analysts have also recently ...
Zolmax
1 year ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating) had its price objective decreased by Truist Financial from $15.00 to $4.00 in a report released on Wednesday, The Fly reports. Truist Financial currently has a buy rating on the stock. Several other analysts have also weighed in on the company. ...
PR Newswire
1 year ago
Thinking about buying stock in Taysha Gene Therapies, Nio, Traeger, Amprius Technologies, or Sellas Life Sciences? Thinking about buying stock in Taysha Gene Therapies, Nio, Traeger, Amprius Technologies, or Sellas Life Sciences? PR Newswire NEW YORK, Oct. 25, 2022 NEW YORK, Oct. 25, 2022...
Ticker Report
1 year ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating) had its price objective cut by research analysts at Chardan Capital from $34.00 to $32.00 in a research report issued on Friday, Marketbeat Ratings reports. The brokerage presently has a buy rating on the stock. Several other ...
Frequently Asked Questions
Frequently Asked Questions
What is Taysha Gene Therapies Inc share price today?
plus_minus_icon
Can Indians buy Taysha Gene Therapies Inc shares?
plus_minus_icon
How can I buy Taysha Gene Therapies Inc shares from India?
plus_minus_icon
Can Fractional shares of Taysha Gene Therapies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Taysha Gene Therapies Inc stocks?
plus_minus_icon
What is today’s traded volume of Taysha Gene Therapies Inc?
plus_minus_icon
What is today’s market capitalisation of Taysha Gene Therapies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Taysha Gene Therapies Inc?
plus_minus_icon
What percentage is Taysha Gene Therapies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Taysha Gene Therapies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.17
$0.53
(19.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00